Entry Detail



General Information

Database ID:exR0012342
RNA Name:RPL3
RNA Type:mRNA
Chromosome:chr22
Starnd:-
Coordinate:
Start Site(bp):39312882End Site(bp):39320389
External Links:ENSG00000100316



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABLIM1
chr10
114431113
114768061
-
AC046185.1
chr17
63702845
63752097
-
ACSS1
chr20
25006230
25058980
-
AIF1L
chr9
131096476
131123152
+
AC105052.3
chr7
102637049
102671641
-
AKAP11
chr13
42272152
42323261
+
AHCYL1
chr1
109984765
110023742
+
ADK
chr10
74151202
74709963
+
ADORA2A
chr22
24417879
24442357
+
ADCY5
chr3
123282296
123449758
-
ALDOA
chr16
30064164
30070457
+
ADAMTS19
chr5
129460281
129738683
+
AC012254.2
chr18
47108188
47176345
-
ADGRG5
chr16
57542643
57591681
+
AC023055.1
chr12
55757275
55827546
-
AC002985.1
chr19
18907013
18934397
-
AC073508.2
chr17
40627356
40665141
-
AC011448.1
chr19
19516227
19536076
+
AFG3L2
chr18
12328944
12377227
-
ADD1
chr4
2843857
2930076
+
AC018523.2
chr11
14493783
14520344
-
AGBL3
chr7
134986508
135147963
+
AC010422.3
chr19
12643831
12648397
-
ACO2
chr22
41469117
41528989
+
AKR1B1
chr7
134442356
134459284
-
AL136454.1
chr1
192716132
192716653
+
AC129492.3
chr17
8150816
8162975
-
AASDHPPT
chr11
106075501
106098699
+
ACTG1
chr17
81509971
81523847
-
AARSD1
chr17
42950526
42964498
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC005899.4
chr17
32328441
32329395
+
AC007780.1
chr17
68413623
68524949
+
AC007952.4
chr17
19112000
19112636
-
AC021078.1
chr5
149494314
149504670
-
AC022211.4
chr17
75138416
75141350
-
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC026979.2
chr8
30155830
30156232
-
AC091564.7
chr11
6610883
6616594
-
AC109460.3
chr16
28974804
28990775
+
AC113189.2
chr17
7420103
7444081
+
AC113189.4
chr17
7439506
7445966
+
AC115284.1
chr3
51961212
51974031
-
AC132217.1
chr11
2129121
2129964
-
AC239868.1
chr1
149861271
149862504
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL136419.1
chr14
23969931
24051377
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.